Head-to-head comparison
Lttl vs Rebody Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Lttl (pronounced “little”) publishes its entire term ladder on one public page — every medication, route and commitment length, month-to-month rung included — alongside compounded semaglutide and tirzepatide, a low-dose microdose line and a longevity range.
$199/mo sema · $279/mo tirz · Verified August 2026
Marked down on: One advertised figure is purchasable at no tier: every product card prints the same “from $129/mo”, including tirzepatide, whose own four rungs are $279, $249, $229 and $199
Desk Score
Rebody Health (rebodyhealth.com), operated by Compound Technologies Inc., is a transparent-pricing GLP-1 and wellness telehealth service that publishes prices up front.
From $200/mo (lowest dose rung) sema · From $250/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Individual compounding pharmacies are not named on the marketing site
Rebody Health takes this head-to-head with the higher Desk Score, 79/100 (C+) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Lttl
66/100
C
Rebody Health
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Lttl | Rebody Health |
|---|---|---|
| Semaglutide | $199/mo$199/mo month-to-month (compounded injectable; oral ODT $229/mo; the advertised $129/mo is a $1,548 annual prepay) | From $200/molowest dose rung$200/mo (starting dose, compounded) |
| Tirzepatide | $279/mo$279/mo month-to-month (compounded injectable; the $129/mo on its product card matches no tirzepatide tier — the cheapest is $199/mo on a $2,388 annual prepay) | From $250/molowest dose rung$250/mo (starting dose, compounded) |
| Coverage | Not listed on Lttl's site (checked August 2026) | 47 states |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines. | Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options. |
| Desk Score | 66/100C | 79/100C+ |
The verdict
Desk pick — Rebody HealthRebody Health takes this head-to-head with the higher Desk Score, 79/100 (C+) against 66/100 (C) for Lttl. Lttl still holds its ground where its strengths line up with yours.
Choose Lttl if…
Shoppers who want to see every commitment tier priced before they hand over any details, and who want a low-dose microdose option next to the full-strength lines.
$199/mo sema · $279/mo tirz
Choose Rebody Health if…
Shoppers who want transparent, dose-based GLP-1 pricing with oral, injectable, or brand-name options.
From $200/mo (lowest dose rung) sema · From $250/mo (lowest dose rung) tirz · 47 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Lttl · Rebody Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Lttl
- CoreAge Rx vs Rebody Health
- Lttl vs Shed
- Rebody Health vs Shed
- Lttl vs Vaylen
- Rebody Health vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.